Pamlico BioPharma
Latest round
- Series A
Last raised
- Apr 2015
Total raised
- $2.2M
Investors
- 2
About Pamlico BioPharma
Pamlico BioPharma, Inc. is based in the US and develops human monoclonal antibody therapeutics for the treatment of human pathogens, cancer, and autoimmune diseases.
Who invested in Pamlico BioPharma
2 investors across 1 round
See all investors in Pamlico BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 29, 2015
Amount
$2.2M
Investors
Questions about Pamlico BioPharma
Who invested in Pamlico BioPharma?
Pamlico BioPharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pamlico BioPharma raised?
Pamlico BioPharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pamlico BioPharma last raise money?
Pamlico BioPharma's most recent round on record is a Series A, in Apr 2015.
What does Pamlico BioPharma do?
Pamlico BioPharma is a biotechnology company.
Where is Pamlico BioPharma headquartered?
Pamlico BioPharma is headquartered in Oklahoma City, US.
Which VCs invest in companies like Pamlico BioPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pamlico BioPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pamlico BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.